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Department of Dermatology, University of Miami School of M edicine, Miami, Florida 
A number of chemotherapeut ic drugs have been subjected to in travaginal test ing in mice to 
measure t heir local inh ibitory activity on DNA, RNA, and protein synt hes is in vagin al 
ep it helium. The drugs have been tested at various concentrations and in different vehicl es 
and evaluated by autoradiographic tec hniques. System ic abso rpt ion of the drugs was 
monitored by simul taneous study of t he gastrointest ina l mucosa of t he rectu m . Methotrexate 
inhibited deoxyuridine incorporat ion in to DNA in both vagina l and rectal epithelium. 
Several lipid-so luble analogues of methotrexate were found to have no effect on deoxyuridine 
incorporation . Nitrogen mustard and emet in e have been shown to selectively inhi bit DNA 
and protein synthes is, respect ively, without systemic effects. T hi s animal assay system may 
be usefu l for pred icting the effectiveness of potenti a l dru gs for the topical treatment of 
psori as is . 
System ic chemotherapeutic drugs , pa rticu la rl y 
methot rexate, have been successfu ll y used in the 
treatment of pso riasis [1-3 ]. Because of t he poten-
tial tox icity involved in t he systemic admin istra-
tion of a chemotherapeut ic agent, several attempts 
have been made to find a top ically effect ive agent 
for psorias is. 
At preseilt there is no sui tab le an imal disease 
model for psoriasis which can be used in a drug 
screening program . Therefore, other animal model 
systems have been studied to test potentia l activ-
ity of topical ant i psoriatic drugs (4,5 ]. Van Scott 
and Bonder [4] have shown t hat the vaginal 
mucosa of mice, which has rela t ively rapid prolifer-
ation , is well suited for topical test ing of drugs for 
antimitotic properties . The present report de-
scribes a modificat ion of this vagina l assay to test 
the epitheli al penetrat ion and pharmacologic ac -
tivity of top ica lly ap plied chemothera peuti c 
agents. Effects on DNA, RNA , and prote in synt he-
sis of vagin al ep ith elium were exam ined . 
MATERIALS AND METHODS 
M ethotrexate (MTX), 3' ,5' -di chl oromethot rexate 
(DCM) a nd th e bis-(d im ethyldioctadecy lammonium ) 
salt of MTX (MTX-NH. +) were obta ined from Lederl e 
La borato ri es, Pearl R iver, N . Y" through the co urtesy of 
Drs. J . M. Sm ith a nd G. M. S ieger . Th e dia lkyl esters of 
MTX and DCM were synthes ized and prov ided by Dr. D. 
G. Johns, Hea d, Drug Meta bolis m Section, Labora tory of 
Ch emica l P ha rmaco loh'Y. NRt iona l Ca ncer Ins titute, Na-
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tiona l In stitutes of Hea lth , Bethesd a , Md . Emetine 
hydroxyurea , a nd ni t rogen mustard were purchased fron~ 
S igma, and cyclohex imide a nd act inomyc in D from 
Calbioch em. Cyclo phosphamide was obta in ed from 
Mead Johnson. [m ethyl-3HJThy midine (20.0 Ci/ mmole), 
[6- 3 HJdeoxyuridine (26.4 Ci/ mmole), [5- 3HJuridine (26.1 
Ci/ mmole), and L-14,5- 3 HJleucin e (30.7 Ci/ mmole) were 
purchased from New England Nuclea r. 
A modifi ca tion of th e assay desc ribed by Van Scot t 
and Bonder 14 J was used to test t he loca l pha rm acologic 
act ivity a nd sys temic effects of topica lly a pplied chemo-
t herape ut ic agents . Th e assay cons ists of introducin g 
drugs vaginally in mi ce. T he abi li ty of th ese drugs to 
inhibit t he in corporat ion of appropri ate trit iated prec ur-
so rs into DNA (thymidine or deoxyuridin e), RNA (uri-
dine), a nd protein (l eucine) was measured by autoradiog-
ra phy . Thus, if a top ica l foli c ac id antagon ist s uch as 
MTX in t roduced in travaginally penetrates the vagina l 
epith elium , it should inh ibit dihydrofolate reductase 
act ivity loca lly and prevent [' H jdeoxyuridin e ( [3H lUdR) 
given to th e a nim a l systemica lly from beco min g incorpo-
rated in to the DNA of t he vagina l epithelia l ce lls . 
S imul ta neously, s ignifica nt sys temic a bsurption of th e 
drug occurring after intravaginal administ rat ion is moni-
to red by th e inhib ition of t he triti um -labeled prec ursor 
in corporat ion into proliferati ng gast rointes tina l epithe-
li a l ce lls o f the rectum. Vagin a l and rectal sections were 
studied en bloc autora diographi ca lly . 
Virgina l fem a le Sw iss mice, 5 to 6 weeks of age, 
obta in ed from Ca mm Resea rch, Wayne, N. J ., were used 
fo r t he st udies. Vagin al s mea rs were ta ken prior to each 
experiment and only those a nim als in the estrogenic 
phase of t he est rus cycle, whi ch has the greates t vaginal 
epitheli a l ce ll proli ferat ion, were used for t he experi -
ments [6 ]. Histo logic exam ination of the vaginal mucosa 
was used to confirm the est rogenic ph ase of t he cycle, 
pri or to a nalys is . 
Autoradiographic evaluation of intra vaginal/y admin -
ist ered drugs . MTX, OCM , and their di a lkyl es ters were 
made up in concent ra tions of 1 % and 2% in an emu ls ified 
petrolatum base and placed in a 1-ml sy ringe fi t t ed with 
a blunt lS-ga uge needle. The remainin g drugs were made 
up in H 2 0 at the concentrat ion in dicated. The dru gs were 
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ad minist ered intravagin a lly in a vo lume of 0.05 ml at 
t ime zero and aga in in 2 hr. Two hours follow ing th e 
second drug treatment, 50 /l Ci ofthe appro pri ate isotope 
in 0 .20 ml of sa line was ad ministered in t ra peri toneally. 
One hour late r both the vagin a a nd the rectum were 
dissected en bloc and fi xed in Bou in 's fix ative for 24 hr. 
T h e t issues were prepared histologica lly fo r a utoradiogra-
phy [7 j . The slid es were coated with Kod a k NTB-2 liquid 
nucl ea r trac k e muls ion for 2 to 6 weeks, developed , a nd 
sta ined. A minimum of 3 a nima ls was employed for eac h 
t reatment gro up . T hree sections from each dissection 
were a na lyzed. The labelin g index of th e vagin al mucosa 
was determin ed by coun t in g those labeled cell in t he 
lo wer basa l row of t he proliferat ive compa rtm en t. The 
systemi c elTect of t he drug was determined by t he 
o bserved effect on DNA synth esis in th e recta l mucosa as 
determined by a qualitative co mpos ite a nalys is of the 
number of DNA-synth es izin g cells and gra in content per 
cell . 
In those studi es (see Table V) in which the selective 
effe ct of a to pically administered drug on DNA, RNA , 
a nd protein synth esis was exa mined , the extent of 
vag ina l a nd recta l mucosa la beling was qualitatively 
judged , based on a compos ite ana lys is of gra in content 
a nd number of labeled cells, a nd rated on a relative sca le 
o f no ( - ), parti a l ( + ), or comp lete ( ) inhi bition of 
p recursor in co rpora tion vs untreated control ani ma ls. 
Study of extended intrauoffinal drug application.s. T he 
s tudy was star ted with mi ce in estrus with a minimum of 
3 a nim a ls per treat ment group . ~ II dru gs in 0.05 ml were 
a dministered in t rm'agin a lly at 8 AM and again a t 4 PM on 
days 1 through 3. On day 4, 50 il Ci l' H IUdR was given 
intra peri tonea lly at 8 AM a nd t he vagina and rectum 
r e moved 1 hI' later. Each t iss ue was washed wi th sa lin e, 
we ighed, and homogeni zed in 2.5 ml of cold ethanol: eth er 
(3: 1). The nucleic aci ds were prec ipita ted and washed 3 
ti m es with cold 0.25 N P CA to remove the ac id-soluble 
r a dioactivity . The nucl eic ac ids were hydrolyzed for L hr 
at 80°C in 0.5 N PCA. T he ext racted rad ioactivity was 
measured in a scintill at ion spectrometer. Counts were 
co rrected for background and q uenchin g a nd expressed as 
DPM / mg of t issue. 
T he a bove t rea tment sc hedu le (2 times/day) waS 
con t inued for 14 days wit.h the sa me dru gs to det ermine 
t he effec t on surviva l. In t hose anim als survivin g t he 
14-day period (DCM treat ment group), DNA synthes is in 
t h e vagina l and t he rec tal mucosa was determin ed as 
described a bove. 
Int radermal druff administration . At t im e zero, 0.10 ml 
con ta in ing va rious co ncent rat ions of d rug (MTX, DCM, 
a nd the diethyl esters ) or vehicle a lone (E mu lphor EL 
620 (GAF Corpora tion) :etha nol:water, 5:5:95) was in-
injected in t raderma lly on the shaved back of a mouse. 
Fo ur an im a ls were u ed for eac h drug concentratiorl. 
tested. The anim als fo r these experim ents were not. 
preselec ted for the es troge ni c phase of the es trus cycle. 
Two hours a fter drug admini stra tion, 50 il Ci of l'H IUdR 
was injected int ra peritoneally . Afte r L hr the drug-
injected and vehicle- injected sites were biops ied a nd the 
vagin a a nd rectum dissected en bloc and prepa red for 
auto radiography as above . La beling indi ces were deter-
mined for each s kin s pec imen. Approx imately 500 basa l 
cells were co un ted in each spec im en. Th e effec t of 
int raderm a l drug on la belin g in the vagin a l a nd recta l 
mucosa was judged by a co mpos ite qua litati ve a na lys is of 
t he number of DNA -synth es izin g cells and gra in content 
per ce ll and rated on a qua litat ive sca le of no. partia l. or 
co mpl ete inhibition . 
Preparation of vaginal mucosa extract. Vagin al t iss ue 
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was dissected from mice in es trus, washed with cold 0.9% 
NaCI, a nd homogenized in 2.5 vo lum es 0.01 M Tris-H CI, 
pH 7 .5, for 5 30-sec interva ls at 4°C with a Virt is 45 
homogeni zer. The homogenate was centrifuged for 1 hr at 
27, 000 x gat 4°C and t he supernatant fra ct ion used fres h 
as the vagin a l extract. 
A ssay (or hy drolysis of esterified MTX analogues . One 
hundred nanomoles of th e diethyl es ter of MTX and 
DCM were each incubated with 60 il l of vagin al extrac t , 
100 ilmoles Tris- HCI buffer, pH 7.5, in a tota l volume of 
1.0 ml for 20 hr at 37°C . Fifty microli ters of th e reaction 
mixture were spotted on a Kodak thin-layer cellu lose 
plate and developed by ascending chroma tography in 
ethanol:water:acetone (70:20:5). This solvent system 
effe ctively sepa rates the ester whi ch moves nea r the sol-
ven t front, from the nones terified parent compound whi ch 
rema ins near the origin . 
A ssay (or hy droxy lation of MTX analo/?ues . Hydroxyl-
ation of the pteridine ring of MTX a na logues results in 
an ultraviol et spectral shift [8 ]. T o assay for hydroxyla-
t ion the reaction mix tures contained in a volum e of 3 ml: 
s ubstra te, 13 ilmoles; sod ium phosphate buffer. pH 7.5. 
50 ilmoles; a nd Versene Fe-3, LO " g. After recordin g the 
initial ult rav iolet spect rum , 0.10 ml oj" vagin a l exl rac t 
was added , a nd after 4 min , I hr , a nd 2 hr . t he s pectrum 
was aga in recorded . Spectra were taken with a Car~' L4 
recordin g s pectrophoto meter aga in t a reference cuvell e 
in which the substra te was omitted . 
RESULTS 
The m o use vagina l e pithelium in the est rogenic 
phase o f t h e estrus cyc le proli ferates 2 to 3 ti m es as 
rapidly as in t h e progestation a l stage of t h e cycl e 
[61 . The Figure s h ows t h e labe lin g of t he basa l 
layer o f the vagin a l mucosa 1 hI' fol low in g t h e 
systemi c a dmin ist rat ion of [3H1 UdR. The same 
pattern of la beling is seen w ith [JH1thy midine. A 
label in g index (L.I.) of approx imately 50% was 
obta in ed for untreated cont ro l mi ce in t he est ro-
genic phase o f the cycl e. 
Effect of systemically administered MTX ana-
log u es . Preliminary stud ies were don e to d ete rmine 
the e ffect of the folic ac id a ntagonists, MTX an d 
DeM , a dministered system ica lly o n DNA syn the-
sis as meas ured by [JH 1UdR in corporat ion in the 
vagina l and recta l mucosa (Ta b. n. 'MTX at 100 
m g/kg resulted in a 45 % decrease in DNA-sy n t he-
s iz ing cells of vagin a l mucosa, as m eas ured by t he 
FIG. Labelin g by tritiat ed deoxyuridine of basa l layer 
of mouse vagina l epithelium (est rogenic phase!. 
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[3H jUdR labe ling index , and a pa rt ia l to com p lete 
in hi b ition of la beling in t h e rec t a l mucosa as seen 
by a dec rease in gra in conten t per cell. It a p pea rs 
t hat t he rect a l mucosa is m ore sens it ive to inhibi -
t ion by M TX t ha n vagina l mucosa at a given 
syste mi c dose. D CM at 100 m g/kg was less inhi b i-
tory at 6 h r t ha n MTX, as ex pected by t he kn own 
systemic m etaboli c inact ivat ion of t his compound . 
Inhi b it ion by D CM at a 3- hr period, was greater 
t han observed a fter 6 hr. 
Effect of to pically (vaginally) app lied MTX 
analo/?ues on DNA synth esis. The effect of M TX 
and seve ra l lipid-solu ble deri vat ives o f MTX on 
DN A syn thesis as m easured by [3HjUdR incor-
poration in the vagina l an d recta l mucosa was ex-
TABLE I. E ffec t of systemic druM administration on DNA 
synth es is in uaMinal and rectal m ucosa 
Duration Effeci 
Drug" Dose of d ru~ L.1. (±SD) on l abelill ~ (m,,/k,,) treatment ( %) in rectal 
(h r) mucosab 
None 0 0 49 .:3 ±- 7.4 
MTX 100 mg 6 27.:l ± 7.3 + to ++ 
DCM 100 mg 3 26.5 ± 4.5 + 
OCM 100 mg 6 37 .3 ±- 4.5 + 
a Drugs admin iste red in t raperi toneally at ti me 0, and 
isotope int ra pe ri toneally 1 hr prior to biopsy . 
, + + : Complete inh ibition of labeling in recta l mucosa 
from a composite analysis of the nu mber or D A-synthe-
sizin g cells and grain content/cell. + : Partial inhibi t ion. 
- : No inhibi tion. 
TABLE IT . Effec t of topicol/y (u(l!! inal/yl applied folic acid 
antagonists on DNA sy n thes is in the ua/iina l and 
recta l m ucosa 
Loca I effect 0 11 Systemic 
Drug DNA synthesis effec t 
0 11 0 A Drug" concen - in va~in a l synthesis in t rat ion h mucosa 
(A ue. L .I. ±SD) rectal 
m ucosa(' 
Cont rol 0 48.0 ± 7.2 -
MTX 0.5% 35 .8 ± 7.0 + 
1.0% 32. 1 ± 3.1 + 
2.0 '* 29.3 ± 3.7 + 
MTX-d imethyl- 1.0 ')'< 50 .0 7.8 -
ester 2.0% 54.5 ± 5.8 -
MTX-diethyl- 1.0% 52 .1 ± 7.2 -
ester 2.0% 55.6 4.8 -
DCM 1.0% 58 .0 ± 3.0 -
2.0% 51.2 ± 7.4 -
DCM-dim ethyl- 1.0% 53.9 ± 4.6 -
ester 2.0% 44.8 ± 9.0 
-
DCM-diet hyl- 1.0% 59.4 -L 8.7 -
ester 2.0% 55.5 ± 4.6 -
a Drugs adm inistered in travagina lly at t ime 0, and 2 
hr. Isotope given intra peritoneally at 4 hr followed by 
organ dissection at 5 hr. 
• Drug vehi cle: petrolatum. 
c++ : Complete inhibi tion of [' H]UdR labeling of 
recta l mucosa. + : Part ial inhibi tion. - : No inhibi tion. 
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am ined following vagina l admini stration of d ru CT 
(Tab. II). Of the compounds tested , only M TX 
was found to effect ively inhibi t DNA syn t h es is . 
Increas in g M TX concent rat ions, 0 .5%, 1.0%, a nd 
2.0%, res ul ted in increas ing inhibi t ion of DNA 
syn t h es is to 25%, 33%, an d 39% of co n t rol act iv ity 
respectiv ely . At t hese concent rat ions it was not 
poss ibl e to ac hi eve loca l inhibi t ion of vagina l 
mucosa wi t hout so m e systemi c a bsorpt ion leading 
to part ial inh ibition of rectal mucosa. 
The e ffect of vag in a lly ad m inist e red MTX a n a-
logues for extended t ime periods wa exa mined 
employ in g bioch emical tec hniques to assay UdR 
incorporation in to D NA in both vagina l a n d rectal 
mucosa (Tab. III ). Under simila r cond it ions p ro-
longed admini stra ti on of DCM had no e ffect on 
[3H jUdR in corporation in to D N A in eit her t iss u e 
whil e MTX gave com plete inh ibi t ion of both 
vagina l a nd rectal tiss ues. Ad ministrat ion o f 1% 
a mmonium salt o f MTX (MTX -N H, +) inhibi ted 
[3H jUdR incorporation in vagin a a nd rectum 44% 
a nd 55%, res pectively. 
The a bove t hree dru gs at a con~en trat ion of 1 % 
were administered vagin a lly twi ce a day for 14 d ays 
to 3 mice per t reatment group and the effect on 
surv ival was d etermined. MTX t reatm ent res ul ted 
in 1 d eath 0 11 day 5 and 2 d eaths on d ay 6 . 
MTX- NH.+ was less tox ic t ha n M TX, produc in CT 1 
death on d ay 12 a nd 2 d eaths on day 14. No deaths 
or any s igns of tox icity were produced wi t h D CM. 
These resul ts showin g letha l system ic tox ic ity from 
vagina l mucosa l penetrat ion of MTX, bu t not 
D CM , a re cons isten t wi t h t he vag in a l/ rectal 
cha nge in T a bl es II a nd III . 
Effect of intra dermal drug ad m inistration on 
DNA synthesis in sk in. In ord er to dete rmine 
whether MTX a nd its ana logues a re capa ble of 
exertin g a loca l e ffec t in s kin , drugs were a dmini _ 
tered to mice in t raderm a ll y. T he administration of 
0 .5 mg of MTX , D CM , MTX-diethylester , or 
D CM -di ethyleste r completely inhibi ted D NA syn -
t hes is in skin as measured au toradiogra phicall y by 
l3H [deoxyurid ine incorporation (Tab. IV). In t ra-
de rm a l doses o f 0 .1 a nd 0.01 m g res ul ted in 
progress ively less inhibi t ion as measured by t he 
la beling index. T he inhibi tory effects 0 11 D A 
T ABLE III. Effect of extended uagi/w l dru/i t reatment on 
[' H] deoxyuridine incorpora tion into DNA 
Con- Vehicle 
DPM/mg tissue' Dru gO 
ce nt ratio n Vagin a Rectum 
Control 109 717 
MTX 2% Pet rolat um 0 43 
MTX 2% Aqueous 0 22 
MTX-NH, + 1% Petrolatum 61 322 
DCM 2% Pet rolatum 116 690 
DCM 2% Aq ueous 124 723 
, 0 Drugs administered in t ravaginally 2 x /day fo r 3 days 
as described in Mat erials and M ethods. 
b Mea n of 3 determ inat ions. 
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synth es is in vaginal and recta l mucosa were a l 0 
monitored for t hose a nimals receiving in traderma l 
doses of 0.1 and 0.01 mg of drug . For a ll drugs 
tested, doses of 0.1 mg resulted in a partial 
inhibi t ion of labeling in both t he vagina l a nd recta l 
mucosa as judged by a qualitat ive compos it e 
a n a lys is of t he number of DNA-sy n t hes iz ing ce ll s 
and gra in co n ten t per ce ll. However in t raderma l 
doses of 0.01 mg produced loca l inhibition in ski n 
without detecta ble inhi b it ion in vagina l or rec t a l 
mucosa . 
Examination for possible in vitro m etabolism of 
MTX analo~ues by vaRina! mucosa. Systemic 
admin istration of DCM effect ively inhibited vag i-
nal DNA synthes is , and intradermal a dmini t ra-
tion of both DCM an d the diet hylester inhibited 
DNA synthesis in skin. Howeve r, s in ce t here was 
no top ica l effect by these co mpound . t he poss ibil -
ity of drug in act ivat ion or m etabol is m by vagin al 
mucosa was co ns ide red . To test this poss ibi lity 
t h ese com pounds were incubated wi th vaginal 
extract as d esc ribed in Materials and M ethods. 
Prolonged inc ubat ion for 20 hI' failed to s how a ny 
de-esteri ficat ion of t he dimethy l a nd d iet hy l este rs 
TABLE IV . Effect of int radermal dru/? administration all 
DNA synth esis in skin 
Dose Labelinl! 
Dru~ injected indexCi 
(mj!) ( % ) 
Cont ro l 0 2.8 
MTX 0.01 2.5 
O.LO 0.1 
0.50 0 
MTX-diethylester om 1.6 
0.10 0.6 
0.50 0 
OCM 0.01 0.3 
0.10 0. 1 
0.50 0 
OCM-diethylester 0.0 1 1.4 
O.LO 1.0 
0.50 0 
" Average of four different animal specimens. 
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of D CM by t hin -layer chromatography. Tn addit ion 
it was not possibl e to demonstrate hydrox.vlation of 
t he pterid ine rin g of e ither DCM or its dimethyl-
ester by spectral ana ly is. 
Effect of vaRinal/y administe'red chemothera-
peutic drugs on DNA, RNA, and protein synthe-
sis in vaginal epithelium. Inhibi tors of DNA 
syn t hes is (hyd roxy urea [9], cyclophosphamide 
[10 J, ni trogen mustard [10]) , prote in synthes is 
(emeti ne [11- 13], cycloheximide [11- 13 ], and RNA 
synthes is (actinomycin 0 [14]) were studi ed in 1% 
concentrations (Tab. V). Comp lete inhibition of 
DNA sy n t hes is as meas ured by [3H [thymidine 
incorporat ion was obtained onl .v with nitrogen 
mustard. 0 system ic absorption of the drug was 
detected as ev idenced by its lack of effect on t he 
rectal mucosa . Partial inh ibi tion of vaginal epit he-
lia l cell DNA synth es is was obta ined with 5% 
hydroxyu rea. No inhi b it ion of vagina l or recta l 
mucosa was detected with cyclophosphamide. Pa r-
t ial a nd select ive inhibi t ion of vaginal RNA sy n-
t hes is, as m eas ured by [3H] uridine incorporat ion, 
was obta ined with act inomycin D . Cyclohex imide 
had no e ffect on prote in synthesis. whil e emetine 
res ul ted in a select ive an d complete inhibition of 
vagi nal protein synthes is without a ny detectable 
system ic effects. 
DIS CUSS IO N 
The mou e vag in a l a nd recta l mucosa have been 
used prev iously to scree n a ntimi tot ic properties of 
system ica lly [15 ] and locally (4) a ppli ed drugs. 
The present assay employs the ra pid cellul a r 
prol ife rat ion of estrus vag ina l t issue to assess 
topica l act ivity and system ic absorption of various 
classes of chemotherapeutic agents as a screen fo r 
potent ial topica l drugs for the treatment of psoria -
sis. As compared to the antimitotic sc ree n, the 
present assay has a broader capab ili ty of sc reen ing 
va rious clas es of chemotherapeutic agents by 
exam ining t heir d ifferent modes of action. By 
selecting appropria te precursors it is possib le to 
define t h e select ivity of drug action and a lso as ess 
system ic effects. 
Of t he va rious fo lic ac id a ntagonists tested 
T ABLE V. Autoradio/iraph ic analYoSis o(th e effect of va/iinallv applied ch emotherapeutic dru/iS on DNA. RNA. Qnd 
prot ein synth esis in va/iinal and reclal mucosa 
Nitrogen musta rd 
Hydroxyurea 5% 
Cyclophos phamide 
Actinomyc in 0 
Cyclohexim ide 
Emetine 
I'H ILelicinc 
Vagin al Reclal 
++ 
Effect on precursor inco rporal ion 
I' H IUridine 
Vaginal Reclal 
+ 
a All drugs exce pt hydroxyurea assayed in l "f aqueous solution . 
I' H IThymidine 
Vag-inal 
++ 
+ 
Rec tal 
b Relative scale of autoradiographi c analysis of precursor incorporation. + + : Com plete inhibition of precursor 
incorporation. + : Partial inhibition. - : No inhibi tion. 
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topically, only MTX and the am monium salt 
(MTX-NH. +) caused inhibition of vaginal DNA 
synthes is as measured by [3H)UdR incorporation . 
Since all MTX concentrations employed resul ted 
in systemic absorption of the drugs as ev idenced by 
inhibi tion of DNA syn thes is in recta l mucosa, it is 
not poss ible to ascertain whether the inhibi tion of 
vagina l DNA synthesis resulted direc tly from the 
local inhibition of dihydrofolate reductase or was 
mediated by some system ic action of t he drug at 
s ites other t han vagina l mucosa. 
Previous in vitro studies have demonstrated the 
enha nced inhibitory activ ity of DCM and d ia lkyl 
esters of MTX and DCM over t hat of MTX in both 
norma l [16) and psoriatic [17) human s kin . The 
present assay system , however, failed to show, even 
after prolonged administration , any intravagin al 
topica l activi ty of DCM or t he dialkyl esters of 
MTX or DCM. Two possible reasons may be 
considered to expla in the in act ivi ty of these drugs 
int ravaginally. One reason is t he local inact ivat ion 
of drug by t he vaginal mucosa. DCM and the esters 
have both been s hown to be hyd roxylated and 
t hereby inact ivated by mouse liver [18 ]. In mice 
t here is no ev idence of hyd roxylation of t hese 
compounds by tiss ues other t han liver. The present 
study failed to detect hydroxy lat ion by vagin al 
t issue. 
Another possible reason for t he lac k of effect of 
DCM and t he esters may be t he inabil ity to reach 
t he d ihydrofo late red uctase target site in t he 
vaginal basal ep it heli a l cells due either to the lac k 
of release by t he vehicl e or the lack of cellular 
penetration. The present data show that DCM a nd 
the diethyl esters of MTX and DCM are effective 
loca lly in skin and that when adm inistered intra-
dermally (0.1 mg) t hese drugs a re capable of 
inhibiting [3H]UdR incorporation in t he vaginal 
mucosa. Since t hese compounds are severalfold 
more lipid soluble t han MTX [8], they may be 
preferentially reta ined in t he petrolatum vehicle, 
thus preventing effect ive concentrations of t he 
drug from entering the epithelial cells. T his last 
poss ibility has not been experim enta ll y confirmed. 
The screening of va rious classes of chemothera-
peutics agents has shown two drugs that appear to 
exert locally complete and specific inhibition. 
Nitrogen mustard complete ly inhibited DNA syn-
thes is without measurable inhibition of the rectal 
mucosa. These data are cons istent with the find-
in gs of Van Scott and Bonder [4) that nitrogen 
mustard effect ive ly blocks vagina l mitoses without 
systemic absorption. Emetine (NSC 33669), an 
a lkalo id that recent ly has been shown to possess 
antitumor activity [19,20], exhibits a complete and 
selective inhibition of vagina l protein synthe is 
without evidence of systemic absorption. This drug 
may be of value for interruptin g crit ica l steps in 
t he hype rproli fe rative process in psoriasis. Further 
studies on t he mode of action of thi s drug on 
psoriasis are now being pursued. 
The potential applicability of this drug screen 
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model for psoriasis is suggested by the results of 
this study. Nitrogen mustard intravagina lly inhib-
its DNA synthes is locally (without systemic ab-
sorption) and is clinically effective on psoriasis by 
topica l administration [21 ]. MTX partially inhib -
its vaginal mucosa in t he screen but only with 
ev idence of system ic abso rption . In severa l clinical 
studies MTX has been ineffective topica lly for 
psoriasis [22- 28]. In one study , however, MTX was 
reported to work loca lly [27], but others have 
critically interpreted these findin gs to be t he resul t 
of systemic absorption of MTX. Hydroxyurea with 
partial inhibition of DNA synthesis in the assay 
has been ineffect ive clinically after top ica l admin-
istration [28J but effect ive with systemic adminis-
tration [29 ]. As pointed out by Van Scott and 
Bonder [4], lower permeability of ep idermis as 
com pared to vagi na l mucosa does not a llow direct 
predictions to be made concernin g topical effec-
tiveness in sk in. The epidermal barri er in Psoriatic 
epidermis , however, is t hought to be less effective 
than in normal ep iderm is [30], which may render 
t he animal data more comparab le to t he topical 
effects in psorias is . The preliminary test ing of 
agents in human sk in which are found effective in 
t he vaginal assay will be necessary to estab lish t he 
rea l value of this an imal sc reen . 
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